Related Experiment Video
Updated: Apr 17, 2026
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Uncontrolled diabetes resulting in diabetic cardiomyopathy in a young male patient and eventually presenting with a
Konstantinos Kritikos1, Kristina Soitou1, Roxani Kapranou1
1Department of Internal Medicine, General Hospital of Kos "Hippokrates Hospital", Greece.
Insights
Diabetic cardiomyopathy (DCP) is a heart condition in diabetes patients that often goes unrecognized. Early diabetes management in primary care can help prevent severe complications and reduce mortality.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Diabetic cardiomyopathy (DCP) is cardiovascular damage in diabetes patients.
- It involves left ventricular changes and impaired function, independent of other heart conditions.
- DCP can remain subclinical for extended periods.
Observation:
- The presented case highlights the often-subclinical nature of DCP.
- Physicians frequently underdiagnose or overlook this condition.
- There is currently no specific treatment for diabetic cardiomyopathy.
Findings:
- Effective management of diabetes and metabolic abnormalities is crucial.
- Primary care interventions can mitigate DCP development.
- Addressing DCP is vital given the rising prevalence of diabetes.
Implications:
- Increased physician awareness of DCP is essential for early detection.
- Prompt management in primary care settings can prevent severe outcomes.
- Early action can decrease disability and mortality associated with DCP.
Abstract:
Diabetic cardiomyopathy (DCP) is defined as the cardiovascular damage present in diabetes patients, which is characterized by myocardial dilatation and hypertrophy, as well as a decrease in the systolic and diastolic function of the left ventricle, and its presence is independent of the coexistence of ischemic heart disease or hypertension. As in the case of the patient that we present here, DCP may be subclinical for a long time, before the appearance of serious clinical symptoms, signs and complications. DCP is poorly recognized by most physicians. Currently, there is no specific treatment for this pathologic entity. However, proper treatment of diabetes and its metabolic abnormalities in the primary care setting reduces the rates of this serious metabolic complication of diabetes. As this high-risk diabetic population is constantly rising, increasing the awareness of physicians for the serious metabolic complications of diabetes, especially in the primary care setting, will help in taking appropriate and early action towards the prevention of full -blown disease and decreasing disability and mortality.
Related Concept Videos
01:28Diabetic Nephropathy
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:26Type I Diabetes II: Pathophysiology
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...